ScreenShot_2026-04-07_135931_591
Home Technology Platform

Technology Platform

AI Molecular Screening Platform
Pharmaceutical Technology Platform
Biomedical Materials Platform
Supramolecular Materials Platform
微信图片_20260406155832_102_254
AI Molecular Screening Platform
Taking ginsenoside CK as an example, we use AI technology and biomimetic concepts to simulate the transformation process of ginsenosides in the human body and accurately screen the best biological enzyme from nearly 2 million enzymes.
图片10
微信图片_20260407180830_106_254
Pharmaceutical Technology Platform
Covers cutting-edge formulation technologies such as nano-encapsulation and targeted delivery. Taking the star ingredient AuroGlab as an example, it applies the original 28-nanometer encapsulation technology to solve the pain points of easy inactivation and low transdermal penetration of traditional licorice formulations; and integrates the targeted delivery system to accurately guide the active ingredients to act on deep targets in the skin, achieving a breakthrough improvement in brightening and spot-removing effects.
图片12
微信图片_20260407182254_108_254
Biomedical Materials Platform
Covering intelligent responsive materials and biocompatible design technologies, we are committed to developing efficient and controllable drug delivery and tissue repair solutions. Taking the innovative thermosensitive hydrogel as an example, we precisely design poloxamer-based materials to achieve intelligent gelation at body temperature, perfectly encapsulating and protecting the active ingredient ginsenoside CK.
图片14
微信图片_20260407182445_110_254
Supramolecular Materials Platform
By leveraging its dynamic programmability—using intermolecular forces such as hydrogen bonding and hydrophobic interactions—supramolecular structures with pH/enzyme/light-responsive properties can be constructed. For example, β-cyclodextrin encapsulates the styrene groups of pterostilbene through hydrophobic interactions within its cavity. Simultaneously, the hydroxyl groups on the cyclodextrin edge (hydrogen bond donors) form an intermolecular hydrogen bond network with the methoxy oxygen atoms of pterostilbene (hydrogen bond acceptors), creating a stable supramolecular encapsulation complex.
图片17

Production Capacity

  • BioQ R&D Center
    BioQ R&D Center
    Basic research and pilot production lines

    • 23 large-scale R&D equipment

    • 8 functional research laboratories

    • Kilogram-level active ingredient ingredient production

  • Huangpu Production Base
    Huangpu Production Base
    Purification and fermentation ingredient production and processing

    • 10,000 ㎡ production plant

    • 5 ton-level production equipment

    • 35 tons/month solution production capacity


  • Zhongshan Production Base
    Zhongshan Production Base
    Chemical synthesis ingredient production

    • 1,500 ㎡ sterile GMP workshop

    • 4 ton-level reactors

    • 20 tons/month powder production capacity


  • Planned Synthetic Biology Park
    Planned Synthetic Biology Park
    Synthetic biology ingredient production line

    • Planned 32,000 ㎡ synthetic biology park

    • 6,000 ㎡ synthetic biology workshop

    • Hundreds of tons of functional ingredient production capacity every year


TEAM STRENGTH

Team Strength

Sheng-Cai Lin
Sheng-Cai Lin
Academician

  • Academician of the Chinese Academy of Sciences

  • Professor and doctoral supervisor at the School of Life Sciences, Xiamen University

  • Renowned cell biologist and leading scientist in the field of cellular metabolic homeostasis regulation

Anzhang Li
Anzhang Li
Chief R&D Scientist

  • Senior Engineer, PhD in Biochemistry from Xiamen University

  • Distinguished Professor at Yangtze University, South China Agricultural University, and other institutions

  • Won the First Prize of Guangdong Provincial Science and Technology Progress Award; has undertaken 29 vertical projects, including those funded by the National Natural Science Foundation of China; published over 50 research papers; and applied for over 70 international and domestic invention patent

Sen Hou
Sen Hou
Ingredients R&D Scientist

  • PhD in Chemistry and Molecular Biology from Nankai University

  • Outstanding Young Scientist of Poland

  • Former Associate Research Fellow at Jinan University

  • Former Chief Engineer in the R&D department of a renowned beauty brand, specializing in cell biology and molecular biology, and has published nearly 50 SCI papers.

Xin Nie
Xin Nie
Basic Research Scientist

  • Doctor of Sun Yat-sen University, postdoctoral fellow at South China University of Technology. 

  • Has been engaged in basic research in areas such as DNA damage repair and cell aging for a long time. 

  • Have published several SCI papers, applied for multiple Chinese invention patents, and served as the principal investigator for national and provincial-level natural science funds.

Mengxi Tong
Mengxi Tong
Director of Synthetic Biology R&D

  • Master of Jinan University, member of Academician Yao Xinsheng's team, specializing in the biosynthetic pathways of natural products, drug development, synthetic biology, etc. 

  • Participated in the National Natural Science Foundation project and was responsible for the design and implementation of key biosynthesis experiments.

RESOURCE STRENGTH

Resource Strength